A novel TAp73-inhibitory compound counteracts stemness features of glioblastoma stem cells

Thumbnail Image
Molecular_Oncology_-_2024_-_Villoch_Fernandez_-_A_novel_TAp73_inhibitory_compound_counteracts_stemness_features_of.pdf (16.76 MB)
Identifiers
URI: https://hdl.handle.net/10641/7499
ISSN: 1574-7891
DOI: 10.1002/1878-0261.13694

Publication date

2025-03

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Publisher Copyright: © 2024 The Author(s). Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Keywords

TAp73, glioblastoma, glioblastoma stem cells, natural compound, stemness signature, Molecular Medicine, Oncology, Genetics, Cancer Research, SDG 3 - Good Health and Well-being, Journal Article, Yes, yes

Citation

Villoch-Fernandez, J, Martínez-García, N, Martín-López, M, Maeso-Alonso, L, López-Ferreras, L, Vazquez-Jimenez, A, Muñoz-Hidalgo, L, Garcia-Romero, N, Sanchez, J M, Fernandez, A, Ayuso-Sacido, A, Marques, M M & Marin, M C 2025, 'A novel TAp73-inhibitory compound counteracts stemness features of glioblastoma stem cells', Molecular Oncology, vol. 19, no. 3, pp. 852-877. https://doi.org/10.1002/1878-0261.13694

Collections

FACULTAD DE CIENCIAS EXPERIMENTALES